209 related articles for article (PubMed ID: 36672885)
1. High Glucose Increases DNA Damage and Elevates the Expression of Multiple DDR Genes.
Rahmoon MA; Elghaish RA; Ibrahim AA; Alaswad Z; Gad MZ; El-Khamisy SF; Elserafy M
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672885
[TBL] [Abstract][Full Text] [Related]
2. [Application value of DNA damage repair variants in adjuvant therapy of triple negative breast cancer].
Wang X; Yue J; Kang YK; Gao SL; Yuan P
Zhonghua Zhong Liu Za Zhi; 2023 Sep; 45(9):787-795. PubMed ID: 37805443
[No Abstract] [Full Text] [Related]
3. Chinese medicine formula 'Baipuhuang Keli' inhibits triple-negative breast cancer by hindering DNA damage repair via MAPK/ERK pathway.
Mi S; Liu X; Zhang L; Wang Y; Sun L; Yuan S; Cui M; Liu Y
J Ethnopharmacol; 2023 Mar; 304():116077. PubMed ID: 36572327
[TBL] [Abstract][Full Text] [Related]
4. Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.
Khozooei S; Lettau K; Barletta F; Jost T; Rebholz S; Veerappan S; Franz-Wachtel M; Macek B; Iliakis G; Distel LV; Zips D; Toulany M
J Exp Clin Cancer Res; 2022 Aug; 41(1):256. PubMed ID: 35989353
[TBL] [Abstract][Full Text] [Related]
5. Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer.
Lin PH; Chen M; Tsai LW; Lo C; Yen TC; Huang TY; Chen CK; Fan SC; Kuo SH; Huang CS
Cancer Sci; 2020 Apr; 111(4):1375-1384. PubMed ID: 31958182
[TBL] [Abstract][Full Text] [Related]
6. DNA damage response inhibitors: An avenue for TNBC treatment.
Jin J; Tao Z; Cao J; Li T; Hu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
[TBL] [Abstract][Full Text] [Related]
7. DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors.
Shi Y; Jin J; Wang X; Ji W; Guan X
Neoplasia; 2019 Jun; 21(6):533-544. PubMed ID: 31029033
[TBL] [Abstract][Full Text] [Related]
8. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.
Banerjee S; Roy S
Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813
[TBL] [Abstract][Full Text] [Related]
9. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.
Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600
[TBL] [Abstract][Full Text] [Related]
10. Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
Mehta M; Griffith J; Panneerselvam J; Babu A; Mani J; Herman T; Ramesh R; Munshi A
Int J Radiat Biol; 2021; 97(8):1109-1120. PubMed ID: 32052681
[TBL] [Abstract][Full Text] [Related]
11. Bisnaphthalimidopropyl diaminodicyclohexylmethane induces DNA damage and repair instability in triple negative breast cancer cells via p21 expression.
Barron GA; Goua M; Kuraoka I; Bermano G; Iwai S; Kong Thoo Lin P
Chem Biol Interact; 2015 Dec; 242():307-15. PubMed ID: 26499071
[TBL] [Abstract][Full Text] [Related]
12. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
13. Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.
Barba M; Vici P; Pizzuti L; Di Lauro L; Sergi D; Di Benedetto A; Ercolani C; Sperati F; Terrenato I; Botti C; Mentuccia L; Iezzi L; Gamucci T; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M
BMC Cancer; 2017 Feb; 17(1):101. PubMed ID: 28166748
[TBL] [Abstract][Full Text] [Related]
14. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
15. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
Front Genet; 2021; 12():721873. PubMed ID: 34408776
[No Abstract] [Full Text] [Related]
16. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
[TBL] [Abstract][Full Text] [Related]
17. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.
Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
[TBL] [Abstract][Full Text] [Related]
18. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract][Full Text] [Related]
19. Endometrial DNA damage response is modulated in endometriosis.
Bane K; Desouza J; Shetty D; Choudhary P; Kadam S; Katkam RR; Fernandes G; Sawant R; Dudhedia U; Warty N; Chauhan A; Chaudhari U; Gajbhiye R; Sachdeva G
Hum Reprod; 2021 Jan; 36(1):160-174. PubMed ID: 33246341
[TBL] [Abstract][Full Text] [Related]
20. DNA damage repair genes controlling human papillomavirus (HPV) episome levels under conditions of stability and extreme instability.
Edwards TG; Vidmar TJ; Koeller K; Bashkin JK; Fisher C
PLoS One; 2013; 8(10):e75406. PubMed ID: 24098381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
